****** Lung Cancer Surgery Market worth 29.99 Billion USD by 2021 – MarketsandMarkets

The report “Lung Cancer Surgery Market by Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy), Minimally Invasive), Device (Surgical (Clamps, Forceps, Retractors, Stapler), Monitoring (Camera, Trocar), Endoscopic Instrument) – ****** Forecast to 2021″, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, and strategies impacting the lung cancer surgery market along with the estimates and forecasts of the revenue and market share analysis.

Browse 85 market data tables and 44 figures spread through 135 pages and in-depth TOC on “Lung Cancer Surgery Market by Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy), Minimally Invasive), Device (Surgical (Clamps, Forceps, Retractors, Stapler), Monitoring (Camera, Trocar), Endoscopic Instrument) – ****** Forecast to 2021″
Get Free PDF – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222

The lung cancer surgery market is projected to reach USD 29.99 Billion by 2021 from USD 21.58 Billion in 2016, at a CAGR of 6.8% from 2016 to 2021. The major factors driving the growth of this market are increasing incidence and prevalence of lung cancer, rapid growth in the aging population, and growing healthcare expenditure worldwide.

The report segments this market based on device, procedure, and region. On the basis of device, the market is segmented into surgical instruments, monitoring and visualizing systems, and endosurgical equipment. In 2016, the surgical instruments segment is expected to account for the largest share of the market. The large share of this segment can primarily be attributed to the short lifespan (6 months–1 year) of hand instruments and widespread adoption of these devices.

Know more about Lung Cancer Surgery Market – https://www.marketsandmarkets.com/PressReleases/lung-cancer-market.asp